Fidelity Adv Biotech-IFBTIX
13F holders, Q2 2026 (June 30)2holders +1
1new positions
0sold out
$50.18avg. 13F price*
At the end of Q2 2026, 2 institutions reported holding Fidelity Adv Biotech-I (FBTIX) in their 13F filings, up 1 from Q1 2026. 1 opened new positions and 0 sold out. The largest holders were Sequent Asset Management, LLC ($1.0M) and Vermillion Wealth Management, Inc. ($50K).
- Company
- Fidelity Adv Biotech-I
- CUSIP
- 315918466
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $50K |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 994 shares bought, net +994 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Sequent Asset Management, LLC | 0.42% | No change | 19,965 | $1.0M |
| Vermillion Wealth Management, Inc. | 0.01% | New | 994 | $50K |
"% of holder's portfolio" is FBTIX's weight in each manager's 13F, not the share of Fidelity Adv Biotech-I the manager owns.